While many genes can affect your risk of developing Alzheimer’s, most have a very small effect. The most common gene linked to late-onset Alzheimer’s…
Across Alzheimer’s disease and other dementias, protein plaques and deposits in the brain — like beta-amyloid, tau, and TDP-43 — are linked to inflammation,…
Our brains change more rapidly at various times of our lives, as though life’s clock was ticking faster than usual. Childhood, adolescence and very…
While Alzheimer’s disease isn’t curable, research shows it may be preventable or postponable by controlling lifestyle factors like diet. Yet, with so many diets…
In the 1840s, near Utah’s Great Salt Lake, a little piece of DNA went haywire. This genetic malfunction gave rise to a rare disorder…
Cognitive decline and dementia already affect more than 55 million people worldwide. This number is projected to skyrocket over the next few decades as…
Wildfires, gasoline, oil, and wood fuels release plumes of pollutants that negatively impact lung and brain health. Most of these health risks come from…
Two thirds of people diagnosed with Alzheimer’s are women. Research shows that the Alzheimer’s biomarker tau protein accumulates differently and more quickly in women’s…
Every cell in the body has a circadian rhythm. This rhythm follows a near 24-hour cycle that is synchronised to day and night. These…
Despite years of experience in the medical field, Dr. Sandeep Jauhar found himself having to learn new tactics and practice empathetic caregiving, a process…
Mild cognitive impairment – an early stage of dementia – is widely under-diagnosed in people 65 and older. That is the key takeaway of…
Two years ago, I started waking up exhausted. It didn’t matter how long I slept. I’d find myself nodding off at my computer. Whenever…
Can you pass me the whatchamacallit? It’s right over there next to the thingamajig. Many of us will experience “lethologica”, or difficulty finding words,…
When neurologists first studied the brains of people with Alzheimer’s, more than 100 years ago, they spotted two abnormal clumps of proteins — beta-amyloid…
As the vast majority of Alzheimer’s drugs fail in clinical trials, some researchers and companies are turning to non-invasive neurotechnology as an alternative approach…